Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Similar articles for PubMed (Select 15716706)

1.

Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

López B, González A, Lasarte JJ, Sarobe P, Borrás F, Díaz A, Barba J, Tomás L, Lozano E, Serrano M, Varo N, Beloqui O, Fortuño MA, Díez J.

J Hypertens. 2005 Mar;23(3):625-32.

PMID:
15716706
2.

Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients.

González A, López B, Martín-Raymondi D, Lozano E, Varo N, Barba J, Serrano M, Díez J.

J Hypertens. 2005 Dec;23(12):2297-304.

PMID:
16269972
3.

Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications.

López B, González A, Querejeta R, Barba J, Díez J.

J Hypertens. 2009 Feb;27(2):418-24. doi: 10.1097/HJH.0b013e32831ac981.

PMID:
19155793
4.

Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension.

López B, Castellano JM, González A, Barba J, Díez J.

Hypertension. 2007 Nov;50(5):977-83. Epub 2007 Sep 10.

5.

Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.

Querejeta R, Varo N, López B, Larman M, Artiñano E, Etayo JC, Martínez Ubago JL, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindán JP, Díez J.

Circulation. 2000 Apr 11;101(14):1729-35.

6.

Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy.

Kohno M, Yasunari K, Yokokawa K, Horio T, Kano H, Minami M, Ikeda M, Yoshikawa J.

Metabolism. 1996 Nov;45(11):1326-9.

PMID:
8931634
7.

Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease.

Cottone S, Nardi E, Mulè G, Vadalà A, Lorito MC, Riccobene R, Palermo A, Arsena R, Guarneri M, Cerasola G.

Clin Nephrol. 2007 Apr;67(4):209-16.

PMID:
17474556
8.

Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.

Díez J, Laviades C, Mayor G, Gil MJ, Monreal I.

Circulation. 1995 Mar 1;91(5):1450-6.

9.

Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch.

Pemberton CJ, Raudsepp SD, Yandle TG, Cameron VA, Richards AM.

Cardiovasc Res. 2005 Oct 1;68(1):109-17.

10.

Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension.

Suzuki M, Yamamoto K, Watanabe S, Iwata T, Hamada M, Hiwada K.

Am J Med. 2000 Jun 1;108(8):627-33.

PMID:
10856410
11.

Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives.

Maceira AM, Barba J, Varo N, Beloqui O, Díez J.

Hypertension. 2002 Apr;39(4):923-8.

12.

Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.

Irzmański R, Banach M, Piechota M, Kowalski J, Barylski M, Cierniewski C, Pawlicki L.

Clin Exp Hypertens. 2007 Apr;29(3):149-64.

PMID:
17497342
13.

Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide.

Nakahara T, Takata Y, Hirayama Y, Asano K, Adachi H, Shiokawa G, Sumi T, Ogawa T, Yamashina A.

Circ J. 2007 May;71(5):716-21.

14.

Brain natriuretic peptide as a cardiac hormone in essential hypertension.

Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara N, et al.

Am J Med. 1992 Jan;92(1):29-34.

PMID:
1530996
15.

B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.

Almeida P, Azevedo A, Rodrigues R, Dias P, Friões F, Vazquez B, Abreu-Lima C, Bettencourt P, Barros H.

Rev Port Cardiol. 2003 Mar;22(3):327-36. English, Portuguese.

16.

Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study.

Morillas P, Castillo J, Quiles J, Nuñez D, Guillén S, Maceira A, Rivera M, Bertomeu V.

Rev Esp Cardiol. 2008 Sep;61(9):972-5. English, Spanish.

17.

Troponin I serum concentration: a new marker of left ventricular hypertrophy in patients with essential hypertension.

Siciliano M, Mettimano M, Dondolini-Poli A, Ballarin S, Migneco A, Annese R, Fazzari L, Fedeli P, Montebelli MR, Zuppi C, Savi L.

Ital Heart J. 2000 Aug;1(8):532-5.

PMID:
10994933
18.

TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension.

Lindsay MM, Maxwell P, Dunn FG.

Hypertension. 2002 Aug;40(2):136-41.

19.

Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.

Demir M, Acartürk E, Inal T, Attila G, Dönmez Y, Avkaroğullari M, Cayli M.

Cardiovasc Pathol. 2007 Mar-Apr;16(2):69-74.

PMID:
17317538
20.

Association of phagocytic NADPH oxidase activity with hypertensive heart disease: a role for cardiotrophin-1?

Moreno MU, San José G, Pejenaute Á, Landecho MF, Díez J, Beloqui Ó, Fortuño A, Zalba G.

Hypertension. 2014 Mar;63(3):468-74. doi: 10.1161/HYPERTENSIONAHA.113.01470. Epub 2013 Dec 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk